Schmermund Axel, Lehmann Nils, Bielak Lawrence F, Yu PanFong, Sheedy Patrick F, Cassidy-Bushrow Andrea E, Turner Stephen T, Moebus Susanne, Möhlenkamp Stefan, Stang Andreas, Mann Klaus, Jöckel Karl-Heinz, Erbel Raimund, Peyser Patricia A
Department of Cardiology, University Clinic Essen, Germany.
Atherosclerosis. 2007 Nov;195(1):e207-16. doi: 10.1016/j.atherosclerosis.2007.04.009. Epub 2007 May 29.
On the basis of the Framingham risk algorithm, overestimation of clinical events has been reported in some European populations. Electron-beam computed tomography-derived quantification of coronary artery calcification (CAC) allows for non-invasive assessment of coronary atherosclerosis in the general population and may thus add important in vivo information on the path from risk factor exposure to formation of clinical events. The current study was undertaken to compare the relationship between risk factors and subclinical coronary atherosclerosis between non-Hispanic white cohorts in Germany and US-America, the hypothesis being that subclinical coronary atherosclerosis might be less prevalent in Europe at the same level of classical risk factor exposure.
The Heinz Nixdorf Recall (HNR) study, conducted in the German Ruhr area and the Epidemiology of Coronary Calcification (ECAC) study, conducted in Olmsted County, Minnesota, both recruited large unselected cohorts, men and women aged 45-74 years, from the general population. All subjects with no history of coronary artery disease (CAD) or stroke were included (n=3120 in HNR, n=703 in ECAC). Coronary risk factors were assessed by personal and computer-assisted interviews and direct laboratory measurements. Cardiovascular medication use (antihypertensive, lipid-lowering, and anti-diabetic) was noted. CAC scores were determined using the Agatston method in an identical fashion in both studies.
Adverse levels of risk factors were more prevalent, and the Framingham risk score was higher (10.6+/-7.6 versus 9.3+/-7.1, p<0.001) in HNR than ECAC, respectively. There was no difference in body mass index (BMI). CAC scores were greater in HNR than in ECAC (mean values, 155.7+/-423.0 versus 107.2+/-280.0; median values, 11.9 versus 2.4; p<0.001, respectively). When subjects were matched on CAD risk factors, presence and quantity of CAC were similar in the 2 cohorts. Risk factors significantly associated with CAC score in both studies included: age, male sex, current and former smoking, systolic blood pressure, and non-HDL-cholesterol. Inferences were similar after excluding subjects using lipid- or blood pressure-lowering medications. Using the same risk factor variables for modelling, the predicted CAC scores were comparable in both cohorts.
In the higher-risk German cohort, presence and quantity of CAC were greater than in the lower-risk US-American cohort. Risk factor associations with CAC were very similar in both unselected populations. We could not demonstrate a relative increase in subclinical coronary atherosclerosis in the US-American cohort. It appears possible to compare CAC as a measure of subclinical coronary artery disease in different populations on different continents, and accordingly, scanning guidelines might be translated across these populations.
基于弗雷明汉风险算法,在一些欧洲人群中已报告临床事件被高估。电子束计算机断层扫描衍生的冠状动脉钙化(CAC)定量分析可对普通人群的冠状动脉粥样硬化进行无创评估,因此可能为从危险因素暴露到临床事件形成的过程增加重要的体内信息。本研究旨在比较德国和美国非西班牙裔白人队列中危险因素与亚临床冠状动脉粥样硬化之间的关系,假设是在相同水平的经典危险因素暴露下,欧洲亚临床冠状动脉粥样硬化的患病率可能较低。
在德国鲁尔地区进行的海因茨·尼克斯多夫召回(HNR)研究和在明尼苏达州奥尔姆斯特德县进行的冠状动脉钙化流行病学(ECAC)研究,均从普通人群中招募了大量未经过筛选的队列,年龄在45 - 74岁之间的男性和女性。纳入所有无冠状动脉疾病(CAD)或中风病史的受试者(HNR中n = 3120,ECAC中n = 703)。通过个人和计算机辅助访谈以及直接实验室测量来评估冠状动脉危险因素。记录心血管药物使用情况(抗高血压药、降脂药和抗糖尿病药)。两项研究均以相同方式使用阿加斯顿方法确定CAC评分。
HNR中危险因素的不良水平更为普遍,且弗雷明汉风险评分更高(分别为10.6±7.6与9.3±7.1,p < 0.001),高于ECAC。体重指数(BMI)无差异。HNR中的CAC评分高于ECAC(平均值,155.7±423.0与107.2±280.0;中位数,11.9与2.4;p均< 0.001)。当根据CAD危险因素对受试者进行匹配时,两个队列中CAC的存在情况和数量相似。两项研究中与CAC评分显著相关的危险因素包括:年龄、男性、当前和既往吸烟、收缩压以及非高密度脂蛋白胆固醇。在排除使用降脂或降压药物的受试者后,推断结果相似。使用相同的危险因素变量进行建模时,两个队列中预测的CAC评分相当。
在风险较高的德国队列中,CAC的存在情况和数量高于风险较低的美国队列。在两个未经过筛选的人群中,危险因素与CAC的关联非常相似。我们未能证明美国队列中亚临床冠状动脉粥样硬化有相对增加。似乎可以在不同大陆的不同人群中比较作为亚临床冠状动脉疾病指标的CAC,因此,扫描指南可能适用于这些人群。